Liposomal Doxorubicin Market Projected to Reach USD 2.96 Billion by 2036
Rockville, MD., September 22, 2026 — The Liposomal Doxorubicin Market is projected to grow from USD 1.48 billion in 2026 to USD 2.96 billion by 2036, advancing at a 7.2% CAGR, according to Fact.MR. The market was valued at approximately USD 1.38 billion in 2025 and is expected to create an absolute dollar opportunity of USD 1.49 billion between 2026 and 2036. The market covers pegylated...
0 Comments 0 Shares 4 Views 0 Reviews